期刊文献+

实验性自身免疫性脑脊髓炎小鼠中枢神经组织中ZO-1 mRNA的变化及益肾达络饮对其的影响 被引量:4

The Expression of ZO-1 mRNA in the Central Nervous System and the Effect of Yishendaluo Decoction in Experimental Autoimmune Encephalomyelitis
暂未订购
导出
摘要 目的研究血脑屏障紧密连接蛋白在EAE发病中的作用,观察中药复方益肾达络饮干预实验性自身免疫性脑脊髓炎(EAE)的疗效和作用机制。方法采用荧光定量PCR测定免疫后不同时间点EAE小鼠中枢神经组织中ZO-1 mRNA表达的变化。结果中药复方益肾达络饮可以显著改善EAE模型小鼠神经功能评分。与正常组相比,激素组、中药组在免疫后14、24、40 d ZO-1 mRNA在EAE小鼠大脑中表达均未见显著改变,而脊髓中在免疫后第14日显著降低;在免疫后14、24、40 d模型组小鼠脊髓中ZO-1 mRNA表达均显著降低。结论 ZO-1是实验性自身免疫性脑脊髓炎血脑屏障破坏的一个重要因素;中药复方益肾达络饮能有效改善EAE小鼠神经功能损伤,其干预EAE的作用机制与血脑屏障紧密连接蛋白调节密切相关。 Objective: To elucidate the contribution of ZO-1 in the CNS to the clinical course of EAE mice,and to explore the efficiency and the mechanism of Yishendaluo Decoction to experimental autoimmune encephalomyelitis.Methods: RT-PCR was used to quantify the gene expression levels of ZO-1 in the CNS tissue of mice at different time points of EAE including pre-onset,onset,peak and chronic after immunization.Results: Compared with model group,Yishendaluo Decoction treatment of EAE could improve the neurological function score.Compared with normal group,ZO-1 mRNA levels of the cerebrum in hormone-treated group and Decoction-treated group were not significantly decreased at different time points of EAE including 14,24 and 40 days after immunization,but ZO-1 mRNA levels in the spinal cord in hormone-treated group and Decoction-treated group were significantly decreased only at 14 days.ZO-1 mRNA levels of the spinal cord in hormone-treated group and Decoction-treated group were significantly decreased including 14,24 and 40 days after immunization.Conclusion: ZO-1 plays an important role to the damage of blood-brain barrier in EAE,Treatment with Yishendaluo Decoction can significantly improve the neurological function score.The therapeutic mechanism of Yishendaluo Decoction was to mediate the expression of tight junctions.
出处 《中国中医急症》 2012年第12期1936-1938,共3页 Journal of Emergency in Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81072770)
关键词 多发性硬化 实验性自身免疫性脑脊髓炎 免疫炎性细胞 益肾达络饮 Multiple Sclerosis Experimental Autoimmune Encephalomyelitis ZO-1 mRNA Yishendaluo Decoction
  • 相关文献

参考文献25

  • 1Forster C. Tight junctions and the modulation of barrier function indisease[J]. Histochem Cell Biol,2008,130(1) :55-70.
  • 2Abbott NJ, Rnnbck L, Hansson E. Astrocyte-endothelial interactionsat the blood-brain bairier[J]. Nat Rev Neurosci,2006,7(l) :41-53.
  • 3Bundgaard M, Abbott NJ. All vertebrates started out with a glialblood-brain barrier 4-500 million years ago[J]. Glia,2008,56(7):699-708.
  • 4Leech S, Kirk J, Plumb J, et al. Persistent endothelial abnormalitiesand blood-brain barrier leak in primary and secondary progressive mul-tiple sclerosis[ J ] . Neuropathol Appl Neurobiol,2007,33(1) : 86-98.
  • 5Stamatovic SM, Dimitrijevic OB, Keep RF, et al. Inflammation andbrain edema : new insights into the role of chemokines and their re-ceptors[J], Acta Neurochir Suppl,2006,96:444-450.
  • 6Lassmann H, Briick W, Lucchinetti CF. The immunopathology ofmultiple sclerosis : an overview[J]. Brain Pathol,2007,17(2):210-218.
  • 7Wekerle H, Lessons from multiple sclerosis : models,concepts,obser-vations [J ]. Ann Rheum Dis,2008,67 (Suppl 3) : 56-60.
  • 8Hochmeister S,Grundtner R,Bauer J, et al. Dysferlin is a new mark-er for leaky brain blood vessels in multiple sclerosis [J]. J NeuropatholExp Neurol,2006,65(9): 855-865.
  • 9Padden M,Leech S,Craig B,et al. Differences in expression of junc-tional adhesion molecule ~A and beta -catenin in multiple sclerosisbrain tissue : Increasing evidence for the role of tight junction patholo-gy[J]. Acta Neuropathol,2007,113(2): 177-186.
  • 10Fabis MJ, Scott GS, Kean, et al. Loss of bloodbrain barrier integrityin the spinal cord is common to experimental allergic encephalomyeli-tis in knockout mouse models [J]. Proc Natl Acad Sci USA, 2007,104.13):5656-5661.

二级参考文献40

  • 1陈萍,陈立云,王拥军.缺血性卒中的神经血管单元保护研究进展[J].中国卒中杂志,2007,2(12):1003-1008. 被引量:15
  • 2石向群,杨金升,石莉,刘秀峰,包仕尧.伊文思蓝、ZO-1评估血脑屏障损伤的应用研究[J].西北国防医学杂志,2004,25(5):329-332. 被引量:16
  • 3廖习清,赖真,李志超.黄芪对脑缺血及缺血再灌注保护机制的研究进展[J].中国中医急症,2006,15(11):1274-1275. 被引量:3
  • 4Simard JM, Kent TH, Chen MK, et al. Brain edema in focal ischemia: molecular pathophysiology and theoretical implications [ J]. Lancet Neurol, 2007,6:258.
  • 5Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [ J ]. Stroke, 1989, 20 : 84.
  • 6Luo YM, Qin Z, Hong Z,et al. Astragaloside Ⅳ protects against ischemic brain injury in a murine model of transient focal ischemia [ J]. Neuroscience Letters, 2004,363:218.
  • 7Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation [ J ]. Am J Physiol Heart Circ Physiol,2002,282 : 1485.
  • 8Zhang WJ, Hufnagl P, Binder BR, et al. Antiinflammatory activity of astragaloside Ⅳ is mediated by inhibition of NF-kappa B activation and adhesion molecule expression [ J ]. Thromb Haemost, 2003, 90: 904.
  • 9Huang JD, Upadhyay UM. Inflammation in stroke and focal cerebral ischemia [ J ]. Surgical Neurology, 2006,66:232.
  • 10Neumann-Haefelin T, Kastrup A, de Crespigny A, et al. Serial MRI after transient focal cerebral ischemia in rats Dynamics of tissue injury, Blood-brain barrier damage, and Edema formation[J]. Stroke, 2000, 31:1965-1973.

共引文献37

同被引文献54

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部